Fukao Katashi | Institute Of Clinical Medicine University Of Tsukuba
スポンサーリンク
概要
関連著者
-
Fukao Katashi
Institute Of Clinical Medicine University Of Tsukuba
-
Ishikawa Akio
筑波大学
-
Ishikawa Akio
Institute Of Clinical Medicine University Of Tsukuba
-
Ishikawa Akio
Inst.of Clin.med. Tsukuba Univ.
-
Tanaka Einosuke
Institute Of Community Medicine And Institute Of Clinical Medicine University Of Tsukuba
-
Tanaka E
Univ. Tsukuba Ibaraki Jpn
-
Takabatake E
Inst.of Commun.med
-
Tanaka Einosuke
Inst.of Commun.med
-
Ishikawa Akio
Institute For Solid State Physics University Of Tokyo
-
Misawa S
Inst.of Commun.med
-
YAMAMOTO Yuji
Inst.of Clin.Med., Tsukuba Univ.
-
Iwasaki Yoji
Institute Of Community Medicine And Institute Of Clinical Medicine University Of Tsukuba
-
Yamamoto Yuji
Inst.of Clin.med. Tsukuba Univ.
-
MISAWA Shogo
Institute of Community Medicine
-
IWASAKI Yoji
Institute of Clinical Medicine, University of Tsukuba
-
Misawa Shogo
Institute Of Community Medicine University Of Tsukuba
-
Misawa Shogo
Inst. Of Commu. Med. Tsukuba Univ.
-
Tanaka Einosuke
Inst. Of Commu. Med. Tsukuba Univ.
-
Tsuji Katsuhisa
Institute Of Clinical Medicine University Of Tsukuba
-
Ohkawa Haruo
Institute Of Clinical Medicine The University Of Tsukuda
-
Ohkawa Haruo
Institute Of Clinical Medicine University Of Tsukuba
-
NAKAMURA Hirofumi
Institute of Clinical Medicine,University of Tsukuba
-
Takabatake E
Department Of Toxicology Faculty Of Pharmaceutical Sciences Setsunan University
-
FUKAO Katashi
Inst.of Clin.Med., Tsukuba Univ.
-
YAMAMOTO Yuji
Institute of Community Medicine and Institute of Clinical Medicine, University of Tsukuba
-
IWASAKI Yoji
Institute of Community Medicine and Institute of Clinical Medicine, University of Tsukuba
-
Nakamura Hirofumi
Institute Of Clinical Medicine University Of Tsukuba
-
ETOH Hironori
Institute of Community Medicine
-
ISHIKAWA Akio
Institute of Clinical Medicine, University of Tsukuba
著作論文
- Age-related changes in hepatic drug-oxidizing activity using trimethadione as a probe drug in human
- A USEFUL MEASURE OF HEPATIC DRUG-OXIDIZING CAPACITY IN HUMANS : CAFFEINE AND TRIMETHADIONE ELIMINATION AS INDICATORS
- The Metabolism and Excretion of Trimethadione in Patients with Percutaneous Transhepatic Biliary Drainage and Renal Dysfunction
- The Impact of Liver Cirrhosis and Cholelithiasis on Phase I and II Reactions Using Antipyrine and Trimethadione as a Model Substrate.